Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Incremental TAG AUC (area under the serum concentration vs
2-dihydrophthalazin-1-one hydrochloride
PDGFR and EGFR respectively)
InChiKey: WHWZLSFABNNENI-UHFFFAOYSA-N
Kinetic analyses of varying concentrations of ABC294640 in the presence of 2
Daclatasvir - CAS# 1009119-64-5 desine calcium salt Incremental TAG AUC (area underDaclatasvir is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antiviral agents to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has yet to be convincingly implicated in cases of clinically apparent liver injury with jaundice. Nevertheless, and for unknown reasons, successful all oral regimens of